Monash IVF Group Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 0/6

Monash IVF Group şirketinin kazançları yıllık ortalama -5.9% oranında azalırken, Healthcare sektörünün kazançları yıllık 10.6% oranında artan oldu. Gelirler yıllık ortalama 11% oranında artan oldu.

Anahtar bilgiler

-5.9%

Kazanç büyüme oranı

-16.6%

EPS büyüme oranı

Healthcare Sektör Büyümesi	15.7%
Gelir büyüme oranı	11.0%
Özkaynak getirisi	-2.4%
Net Marj	-2.6%
Son Kazanç Güncellemesi	30 Jun 2024

Yakın geçmiş performans güncellemeleri

Recent updates

Gelir ve Gider Dağılımı

Monash IVF Group nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.

Kazanç ve Gelir Geçmişi

DB:MIS Gelir, gider ve kazançlar (AUD Millions )
Tarih	Gelir	Kazançlar	G+A Giderleri
30 Jun 24	255	-7	21
31 Mar 24	246	9	20
31 Dec 23	236	24	20
30 Sep 23	225	23	19
30 Jun 23	214	22	18
31 Mar 23	204	19	18
31 Dec 22	195	17	18
30 Sep 22	193	18	18
30 Jun 22	192	18	18
31 Mar 22	193	21	18
31 Dec 21	194	23	17
30 Sep 21	189	24	16
30 Jun 21	184	25	14
31 Mar 21	171	22	13
31 Dec 20	159	18	13
30 Sep 20	152	15	12
30 Jun 20	145	12	12
31 Mar 20	149	15	12
31 Dec 19	152	18	12
30 Sep 19	152	19	12
30 Jun 19	152	20	11
31 Mar 19	151	19	14
31 Dec 18	151	19	17
30 Sep 18	151	20	17
30 Jun 18	151	21	17
31 Mar 18	152	24	17
31 Dec 17	153	26	16
30 Sep 17	154	28	16
30 Jun 17	155	30	16
31 Mar 17	156	30	16
31 Dec 16	156	30	15
30 Sep 16	156	29	16
30 Jun 16	157	29	16
31 Mar 16	150	27	13
31 Dec 15	144	24	9
30 Sep 15	134	23	9
30 Jun 15	125	21	9
31 Mar 15	121	15	8
31 Dec 14	117	8	8
30 Sep 14	115	5	8
30 Jun 14	114	3	9
31 Mar 14	110	2	4
31 Dec 13	106	0	0

Kaliteli Kazançlar: MIS şu anda kârlı değil.

Büyüyen Kar Marjı: MIS şu anda kârlı değil.

Serbest Nakit Akışı ve Kazanç Analizi

Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: MIS kârlı değildir ve zararlar son 5 yılda yılda 5.9% oranında artmıştır.

Büyüme Hızlandırma: MIS 'un son bir yıldaki kazanç büyümesinin 5 yıllık ortalamasıyla karşılaştırılması mümkün değil çünkü şu anda kârlı değil

Kazançlar vs. Sektör: MIS kârlı olmadığından, geçmiş yıl kazanç büyümesinin Healthcare sektörüyle ( 40.5% ) karşılaştırılması zorlaşıyor.

Özkaynak Getirisi

Yüksek ROE: MIS hissesi şu anda kârlı olmadığından negatif Özsermaye Getirisi'ne ( -2.41% ) sahiptir.

Monash IVF Group Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 0/6

Anahtar bilgiler

Yakın geçmiş performans güncellemeleri

Full year 2024 earnings released: AU$0.017 loss per share (vs AU$0.056 profit in FY 2023)

First half 2024 earnings released: EPS: AU$0.033 (vs AU$0.027 in 1H 2023)

Monash IVF Group Limited to Report First Half, 2024 Results on Feb 23, 2024

Full year 2023 earnings released: EPS: AU$0.056 (vs AU$0.047 in FY 2022)

First half 2023 earnings released: EPS: AU$0.027 (vs AU$0.031 in 1H 2022)

Monash IVF Group Limited to Report First Half, 2023 Results on Feb 21, 2023

Recent updates

New minor risk - Share price stability

Monash IVF Group Limited Announces Board Changes

Independent Non-Executive Director recently bought €57k worth of stock

Monash IVF Group Limited Announces Ordinary Fully Franked Dividend for the Six Months Ended June 30, 2024, Payable on October 11, 2024

Full year 2024 earnings released: AU$0.017 loss per share (vs AU$0.056 profit in FY 2023)

Monash IVF Group Limited (ASX:MVF)completed the acquisition of 80% stake in Fertility North Holdings Pty Ltd.

Upcoming dividend of AU$0.025 per share

Monash IVF Group Limited Appoints Cathy Aston as an Independent Non-Executive Director and A Member of the Audit and Risk Management Committee Effective from 26 February 2024

First half 2024 earnings released: EPS: AU$0.033 (vs AU$0.027 in 1H 2023)

First half dividend of AU$0.025 announced

Monash IVF Group Limited to Report First Half, 2024 Results on Feb 23, 2024

Upcoming dividend of AU$0.022 per share at 3.5% yield

Monash IVF Group Limited Announces Fully Franked Final Dividend for Fiscal Year Ended June 30, 2023, Payable on 11 October 2023

Full year 2023 earnings released: EPS: AU$0.056 (vs AU$0.047 in FY 2022)

Monash IVF Group Limited Provides Update on Class Action Lawsuit

Monash IVF Group Limited (ASX:MVF) completed the acquisition of PIVET Medical Centre.

Upcoming dividend of AU$0.022 per share at 4.2% yield

First half 2023 earnings released: EPS: AU$0.027 (vs AU$0.031 in 1H 2022)

Monash IVF Group Limited to Report First Half, 2023 Results on Feb 21, 2023

Insufficient new directors

Monash IVF Group Limited (ASX:MVF) completed the acquisition of ART Associates Queensland #2 Pty Ltd.

Upcoming dividend of AU$0.022 per share

Full year 2022 earnings released: EPS: AU$0.047 (vs AU$0.065 in FY 2021)

Monash IVF Group Limited Announces Ordinary Fully Paid Distribution for the Six Months Ended June 30, 2022, Payable on October 7, 2022

Monash IVF Group Limited to Report Fiscal Year 2022 Results on Aug 26, 2022

Monash IVF Group Limited, Annual General Meeting, Nov 11, 2022

Insufficient new directors

Monash IVF Group Limited (ASX:MVF) agreed to acquire PIVET Medical Centre for AUD 9.4 million.

Insufficient new directors

Monash IVF Group Limited Announces Fully Franked Distribution for the Six Months That Ended December 31, 2021, Payable on April 4, 2022

Monash IVF Group Limited to Report First Half, 2022 Results on Feb 17, 2022

Monash IVF Group Limited Updates Temporary Suspension of IVF Procedures Lifted in Victoria

Upcoming dividend of AU$0.021 per share

Full year 2021 earnings released: EPS AU$0.065 (vs AU$0.046 in FY 2020)

Independent Non-Executive Director recently bought €124k worth of stock

Revenue beats expectations

First half 2021 earnings released: EPS AU$0.037 (vs AU$0.035 in 1H 2020)

New 90-day high: €0.51

New 90-day high: €0.48

New 90-day high: €0.44

Monash IVF Group Limited Provides Earnings Guidance for the Second Half and Full Year of the Fiscal Year 2020

Gelir ve Gider Dağılımı

Kazanç ve Gelir Geçmişi

Serbest Nakit Akışı ve Kazanç Analizi

Geçmiş Kazanç Büyüme Analizi

Özkaynak Getirisi

Varlık Getirisi

Kullanılan Sermaye Getirisi

Geçmişte güçlü performans gösteren şirketleri keşfedin